{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:20:28Z","timestamp":1794666028662,"version":"4.9.1"},"reference-count":116,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Iron deficiency (ID) is common in patients with cardiovascular disease. Up to 60% of patients with coronary artery disease, and an even higher proportion of those with heart failure (HF) or pulmonary hypertension have ID; the evidence for cerebrovascular disease, aortic stenosis and atrial fibrillation is less robust. The prevalence of ID increases with the severity of cardiac and renal dysfunction and is probably more common amongst women. Insufficient dietary iron, reduced iron absorption due to increases in hepcidin secondary to the low-grade inflammation associated with atherosclerosis and congestion or reduced gastric acidity, and increased blood loss due to anti-thrombotic therapy or gastro-intestinal or renal disease may all cause ID. For older people in the general population and patients with HF with reduced ejection fraction (HFrEF), both anaemia and ID are associated with a poor prognosis; each may confer independent risk. There is growing evidence that ID is an important therapeutic target for patients with HFrEF, even if they do not have anaemia. Whether this is also true for other HF phenotypes or patients with cardiovascular disease in general is currently unknown. Randomized trials showed that intravenous ferric carboxymaltose improved symptoms, health-related quality of life and exercise capacity and reduced hospitalizations for worsening HF in patients with HFrEF and mildly reduced ejection fraction (&amp;lt;50%). Since ID is easy to treat and is effective for patients with HFrEF, such patients should be investigated for possible ID. This recommendation may extend to other populations in the light of evidence from future trials.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehac569","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T18:16:58Z","timestamp":1666721818000},"page":"14-27","source":"Crossref","is-referenced-by-count":186,"title":["Iron deficiency and cardiovascular disease"],"prefix":"10.1093","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7732-0887","authenticated-orcid":false,"given":"Gianluigi","family":"Savarese","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Karolinska Institutet , Stockholm , Sweden"},{"name":"Heart and Vascular Theme, Karolinska University Hospital , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Pneumology, University of G\u00f6ttingen Medical Center , G\u00f6ttingen , Germany"},{"name":"German Center for Cardiovascular Research (DZHK), partner site G\u00f6ttingen , G\u00f6ttingen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7683-4720","authenticated-orcid":false,"given":"Javed","family":"Butler","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Mississippi School of Medicine , Jackson, MS , USA"},{"name":"Baylor Scott and White Research Institute , Dallas TX , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G F","family":"Cleland","sequence":"additional","affiliation":[{"name":"Robertson Centre for Biostatistics and Clinical Trials, Institute of Health & Wellebing, University of Glasgow , Glasgow , UK"},{"name":"National Heart & Lung Institute, Imperial College London , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[{"name":"Department of Heart Diseases, Wroclaw Medical University , Wroc\u0142aw , Poland"},{"name":"Centre for Heart Diseases, University Hospital , Wroclaw , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0805-8683","authenticated-orcid":false,"given":"Stefan D","family":"Anker","sequence":"additional","affiliation":[{"name":"Department of Cardiology (CVK) and Berlin Institute of Health Centre for Regenerative Therapies, German Centre for Cardiovascular Research (DZHK) partner site Berlin; Charit\u00e9 Universit\u00e4tsmedizin Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1177\/15648265030244S106","article-title":"Iron deficiency: global prevalence and consequences","volume":"24","author":"Stoltzfus","year":"2003","journal-title":"Food Nutr Bull"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","article-title":"Iron deficiency in heart failure: an overview","volume":"7","author":"von Haehling","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.3390\/ijms22126493","article-title":"Hepcidin-Ferroportin interaction controls systemic iron homeostasis","volume":"22","author":"Nemeth","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"6062094","DOI":"10.1155\/2020\/6062094","article-title":"Regulation of iron homeostasis and related diseases","volume":"2020","author":"Li","year":"2020","journal-title":"Mediators Inflamm"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrcardio.2015.109","article-title":"Iron deficiency and cardiovascular disease","volume":"12","author":"von Haehling","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/HJH.0b013e3283434784","article-title":"Impaired expression of duodenal iron transporters in dahl salt-sensitive heart failure rats","volume":"29","author":"Naito","year":"2011","journal-title":"J Hypertens"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ejhf.1482","article-title":"The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study","volume":"21","author":"Markousis-Mavrogenis","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cardfail.2020.03.004","article-title":"Increased iron absorption in patients with chronic heart failure and iron deficiency","volume":"26","author":"Cabrera","year":"2020","journal-title":"J Card Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.kint.2021.03.020","article-title":"Controversies in optimal anemia management: conclusions from a kidney disease: improving global outcomes (KDIGO) conference","volume":"99","author":"Babitt","year":"2021","journal-title":"Kidney Int"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ejhf.2036","article-title":"High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality","volume":"23","author":"Sierpinski","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"e004519","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients","volume":"11","author":"Beverborg N","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/cvr\/cvz198","article-title":"High-sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death","volume":"116","author":"Pellicori","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1002\/ehf2.13146","article-title":"Ferric carboxymaltose for the treatment of iron-deficient heart failure patients: a systematic review and meta-analysis","volume":"7","author":"Khan","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/CIRCULATIONAHA.119.044235","article-title":"Effect of empagliflozin on erythropoietin levels, iron stores, and red blood cell morphology in patients with type 2 diabetes Mellitus and coronary artery disease","volume":"141","author":"Mazer","year":"2020","journal-title":"Circulation"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"dgaa057","DOI":"10.1210\/clinem\/dgaa057","article-title":"Dapagliflozin suppresses hepcidin and increases erythropoiesis","volume":"105","author":"Ghanim","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00392-016-1073-y","article-title":"Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: the PrEP registry","volume":"106","author":"von Haehling","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00392-018-1344-x","article-title":"Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life","volume":"108","author":"Bekfani","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1002\/ehf2.13661","article-title":"Clinical characteristics of people with heart failure in Australian general practice: results from a retrospective cohort study","volume":"8","author":"Sindone","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","article-title":"Criteria for iron deficiency in patients with heart failure","volume":"79","author":"Masini","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/ehf2.13245","article-title":"Diagnosis and treatment of iron deficiency in heart failure: oFICSel study by the French heart failure working group","volume":"8","author":"Pezel","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/ejhf.2338","article-title":"Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish heart failure registry","volume":"23","author":"Becher","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/20009666.2020.1854927","article-title":"Prevalence and association of iron deficiency with anemia among patients with heart failure in the USA: NHANES 2017\u20132018","volume":"11","author":"Chobufo","year":"2021","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1002\/ehf2.13617","article-title":"Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype","volume":"8","author":"Fitzsimons","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am Heart J"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ehf2.13850","article-title":"Iron deficiency in heart failure patients: the French CARENFER prospective study","volume":"9","author":"Cohen-Solal","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/ejhf.161","article-title":"Iron deficiency in a multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis","volume":"16","author":"Yeo","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ejhf.2251","article-title":"Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure","volume":"24","author":"Graham","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","article-title":"Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival","volume":"58","author":"Okonko","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur Heart J"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jamacardio.2019.1739","article-title":"Differences in clinical profile and outcomes of low iron storage vs defective iron utilization in patients with heart failure: results from the DEFINE-HF and BIOSTAT-CHF studies","volume":"4","author":"Grote Beverborg","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"e001012","DOI":"10.1136\/openhrt-2019-001012","article-title":"Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"6","author":"Beale","year":"2019","journal-title":"Open Heart"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/00015385.2017.1351239","article-title":"Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction","volume":"73","author":"Martens","year":"2018","journal-title":"Acta Cardiologica"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3390\/jcm8101569","article-title":"Iron deficiency in acute decompensated heart failure","volume":"8","author":"Beale","year":"2019","journal-title":"J Clin Med"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijcard.2018.03.039","article-title":"Impact of iron deficiency on long-term clinical outcomes of hospitalized patients with heart failure","volume":"261","author":"Nakano","year":"2018","journal-title":"Int J Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ejhf.139","article-title":"High prevalence of iron deficiency in patients with acute decompensated heart failure","volume":"16","author":"Cohen-Solal","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1093\/eurheartj\/ehu235","article-title":"Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure","volume":"35","author":"Jankowska","year":"2014","journal-title":"Eur Heart J"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiencydagger","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00392-021-01837-8","article-title":"Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials","volume":"110","author":"Graham","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","article-title":"European Consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases","volume":"9","author":"Dignass","year":"2015","journal-title":"J Crohns Colitis"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ejhf.1434","article-title":"Intravenous iron therapy in heart failure: a different perspective","volume":"21","author":"Ghafourian","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ejhf.2092","article-title":"Oral sucrosomial iron improves exercise capacity and quality of life in heart failure with reduced ejection fraction and iron deficiency: a non-randomized, open-label, proof-of-concept study","volume":"23","author":"Karavidas","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jacc.2006.07.015","article-title":"Intravenous iron alone for the treatment of anemia in patients with chronic heart failure","volume":"48","author":"Bolger","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/eurjhf\/hft099","article-title":"Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial","volume":"15","author":"Filippatos","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/eurheartj\/ehr504","article-title":"The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study","volume":"34","author":"Comin-Colet","year":"2013","journal-title":"Eur Heart J"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ejhf.229","article-title":"The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study","volume":"17","author":"Ponikowski","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ehf2.12462","article-title":"Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR-HF substudy","volume":"6","author":"Okonko","year":"2019","journal-title":"ESC Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ejhf.823","article-title":"Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis","volume":"20","author":"Anker","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.amjcard.2021.04.042","article-title":"Safety and efficacy of intravenous ferric derisomaltose compared to iron sucrose for iron deficiency Anemia in patients with chronic kidney disease with and without heart failure","volume":"152","author":"Ambrosy","year":"2021","journal-title":"Am J Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/ehf2.12675","article-title":"The effect of iron deficiency on cardiac resynchronization therapy: results from the RIDE-CRT study","volume":"7","author":"Lacour","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1093\/eurheartj\/ehab411","article-title":"The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy-the IRON-CRT trial","volume":"42","author":"Martens","year":"2021","journal-title":"Eur Heart J"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ehf2.12250","article-title":"Single-dose intravenous iron in southeast Asian heart failure patients: a pilot randomized placebo-controlled study (PRACTICE-ASIA-HF)","volume":"5","author":"Yeo","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/eurheartj\/ehab234","article-title":"The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study","volume":"42","author":"Jankowska","year":"2021","journal-title":"Euro Heart J"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1001\/jama.2015.15572","article-title":"Comparative risk of anaphylactic reactions associated with intravenous iron products","volume":"314","author":"Wang","year":"2015","journal-title":"JAMA"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1002\/ajh.26015","article-title":"Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: the FERWON-IDA\/NEPHRO trials","volume":"96","author":"Wolf","year":"2021","journal-title":"Am J Hematol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2019.22450","article-title":"Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency Anemia: two randomized clinical trials","volume":"323","author":"Wolf","year":"2020","journal-title":"JAMA"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.jacc.2018.03.448","article-title":"High-Dose ferric carboxymaltose in patients with HFrEF induces significant hypophosphatemia","volume":"71","author":"Stohr","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(81)92463-6","article-title":"Iron and the sex difference in heart disease risk","volume":"1","author":"Sullivan","year":"1981","journal-title":"Lancet"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/01.CIR.86.3.803","article-title":"High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men","volume":"86","author":"Salonen","year":"1992","journal-title":"Circulation"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/01.CIR.97.15.1461","article-title":"Association between body iron stores and the risk of acute myocardial infarction in men","volume":"97","author":"Tuomainen","year":"1998","journal-title":"Circulation"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00001648-199403000-00015","article-title":"Serum iron and risk of fatal acute myocardial infarction","volume":"5","author":"Morrison","year":"1994","journal-title":"Epidemiology"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.atherosclerosis.2014.12.018","article-title":"Iron status and its association with coronary heart disease: systematic review and meta-analysis of prospective studies","volume":"238","author":"De S","year":"2015","journal-title":"Atherosclerosis"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/ATVBAHA.117.309757","article-title":"The effect of iron Status on risk of coronary artery disease: a Mendelian randomization study-brief report","volume":"37","author":"Gill","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ejhf.622","article-title":"Serum ferritin and risk for new-onset heart failure and cardiovascular events in the community","volume":"19","author":"Klip","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/ajcn\/nqx014","article-title":"Red meat consumption and risk of cardiovascular diseases-is increased iron load a possible link?","volume":"107","author":"Pacheco DA","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1002\/ehf2.13589","article-title":"Association of iron deficiency with incident cardiovascular diseases and mortality in the general population","volume":"8","author":"Schrage","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408360701713104","article-title":"Oxidative stress and iron homeostasis: mechanistic and health aspects","volume":"45","author":"Galaris","year":"2008","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0021-9150(98)00070-7","article-title":"Lack of association between ferritin level and measures of LDL oxidation: the ARIC study. Atherosclerosis risk in communities","volume":"139","author":"Iribarren","year":"1998","journal-title":"Atherosclerosis"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0021-9150(02)00233-2","article-title":"Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women","volume":"165","author":"Williams","year":"2002","journal-title":"Atherosclerosis"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.2337\/dc13-0528","article-title":"Iron status and survival in diabetic patients with coronary artery disease","volume":"36","author":"Ponikowska","year":"2013","journal-title":"Diabetes Care"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijcard.2014.10.006","article-title":"Bone marrow iron depletion is common in patients with coronary artery disease","volume":"182","author":"Jankowska","year":"2015","journal-title":"Int J Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jacbts.2021.05.004","article-title":"Implications of iron deficiency in STEMI patients and in a murine model of myocardial infarction","volume":"6","author":"Inserte","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/biom8030060","article-title":"Adverse outcome prediction of iron deficiency in patients with acute coronary syndrome","volume":"8","author":"Zeller","year":"2018","journal-title":"Biomolecules"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2019.07.083","article-title":"Iron deficiency in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"300","author":"Cosentino","year":"2020","journal-title":"Int J Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijcard.2020.12.021","article-title":"Iron deficiency for prognosis in acute coronary syndrome\u2014a systematic review and meta-analysis","volume":"328","author":"Reinhold","year":"2021","journal-title":"Int J Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"e015480","DOI":"10.1161\/JAHA.119.015480","article-title":"Iron metabolism contributes to prognosis in coronary artery disease: prognostic value of the soluble transferrin receptor within the AtheroGene study","volume":"9","author":"Weidmann","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"e104495","DOI":"10.1371\/journal.pone.0104495","article-title":"Serum iron concentration, but not hemoglobin, correlates with TIMI risk score and 6-month left ventricular performance after primary angioplasty for acute myocardial infarction","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijcard.2014.02.016","article-title":"Positive effect of intravenous iron-oxide administration on left ventricular remodelling in patients with acute ST-elevation myocardial infarction\u2014a cardiovascular magnetic resonance (CMR) study","volume":"173","author":"Florian","year":"2014","journal-title":"Int J Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/01.STR.0000173172.82880.72","article-title":"Serum ferritin is a risk factor for stroke in postmenopausal women","volume":"36","author":"van der","year":"2005","journal-title":"Stroke"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1161\/STROKEAHA.118.022701","article-title":"Iron Status and risk of stroke","volume":"49","author":"Gill","year":"2018","journal-title":"Stroke"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.numecd.2005.01.001","article-title":"Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects","volume":"15","author":"Marniemi","year":"2005","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000108429","article-title":"Iron stores and HFE genotypes are not related to increased risk of ischemic stroke. A prospective nested case-referent study","volume":"24","author":"Ekblom","year":"2007","journal-title":"Cerebrovasc Dis"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/oxfordjournals.aje.a008855","article-title":"Serum transferrin saturation, stroke incidence, and mortality in women and men. The NHANES I epidemiologic followup study. National health and nutrition examination survey","volume":"144","author":"Gillum","year":"1996","journal-title":"Am J Epidemiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/jcsm.12927","article-title":"Iron deficiency is related to low functional outcome in patients at early rehabilitation after acute stroke","volume":"13","author":"Doehner","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"e000901","DOI":"10.1136\/openhrt-2018-000901","article-title":"Prevalence and prognostic implication of iron deficiency and anaemia in patients with severe aortic stenosis","volume":"5","author":"Kvaslerud","year":"2018","journal-title":"Open Heart"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijcard.2017.06.024","article-title":"Prognostic impact of anemia and iron-deficiency anemia in a contemporary cohort of patients undergoing transcatheter aortic valve implantation","volume":"244","author":"Rheude","year":"2017","journal-title":"Int J Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.amjcard.2019.07.051","article-title":"Prevalence and clinical impact of iron deficiency in patients with severe aortic stenosis referred for transcatheter aortic valve implantation","volume":"124","author":"Rheude","year":"2019","journal-title":"Am J Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/ejhf.2557","article-title":"Intravenous iron supplement for iron deficiency in patients with severe aortic stenosis scheduled for transcatheter aortic valve implantation: results of the IIISAS randomised trial","volume":"24","author":"Kvaslerud","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12872-022-02633-6","article-title":"Anemia and iron deficiency in patients with atrial fibrillation","volume":"22","author":"Hanna-Rivero","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"101001","DOI":"10.1016\/j.cpcardiol.2021.101001","article-title":"Trends and inpatient outcomes of primary atrial fibrillation hospitalizations with underlying iron deficiency Anemia: an analysis of the national inpatient sample database from 2004 -2018","volume":"47","author":"Minhas","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"2023032507264026200_","first-page":"103","article-title":"Iron deficiency and hematinic deficiencies in atrial fibrillation: a new insight into comorbidities","volume":"46","author":"Keskin","year":"2018","journal-title":"Turk Kardiyol Dern Ars"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"e047642","DOI":"10.1136\/bmjopen-2020-047642","article-title":"Rationale and design of the IRON-AF study: a double-blind, randomised, placebo-controlled study to assess the effect of intravenous ferric carboxymaltose in patients with atrial fibrillation and iron deficiency","volume":"11","author":"Tu","year":"2021","journal-title":"BMJ Open"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"e0203396","DOI":"10.1371\/journal.pone.0203396","article-title":"The crucial impact of iron deficiency definition for the course of precapillary pulmonary hypertension","volume":"13","author":"Sonnweber","year":"2018","journal-title":"PLoS One"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.hrtlng.2018.05.002","article-title":"Prevalence of iron deficiency in different subtypes of pulmonary hypertension","volume":"47","author":"Yu","year":"2018","journal-title":"Heart Lung"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/14017431.2019.1567934","article-title":"Iron deficiency in pulmonary arterial hypertension associated with congenital heart disease","volume":"52","author":"Yu","year":"2018","journal-title":"Scand Cardiovasc J"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/rheumatology\/ket331","article-title":"Iron deficiency in systemic sclerosis patients with and without pulmonary hypertension","volume":"53","author":"Ruiter","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1183\/09031936.00100510","article-title":"Iron deficiency is common in idiopathic pulmonary arterial hypertension","volume":"37","author":"Ruiter","year":"2011","journal-title":"Eur Respir J"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2011.02.057","article-title":"Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights","volume":"58","author":"Rhodes","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.hlc.2013.08.007","article-title":"Iron deficiency in patients with idiopathic pulmonary arterial hypertension","volume":"23","author":"van Empel","year":"2014","journal-title":"Heart Lung Circ"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.chest.2021.07.2159","article-title":"Iron deficiency is associated with more severe pulmonary vascular disease in pulmonary hypertension caused by chronic lung disease","volume":"161","author":"Tatah","year":"2022","journal-title":"Chest"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.hlc.2016.04.020","article-title":"Iron deficiency in COPD associates with increased pulmonary artery pressure estimated by echocardiography","volume":"26","author":"Plesner","year":"2017","journal-title":"Heart Lung Circ"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1172\/JCI85715","article-title":"Clinical iron deficiency disturbs Normal human responses to hypoxia","volume":"126","author":"Frise","year":"2016","journal-title":"J Clin Invest"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/jama.2009.1404","article-title":"Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials","volume":"302","author":"Smith","year":"2009","journal-title":"JAMA"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"5669412","DOI":"10.1155\/2021\/5669412","article-title":"Iron metabolism and idiopathic pulmonary arterial hypertension: new insights from bioinformatic analysis","volume":"2021","author":"Zou","year":"2021","journal-title":"Biomed Res Int"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1752-8062.2011.00301.x","article-title":"High levels of zinc-protoporphyrin identify iron metabolic abnormalities in pulmonary arterial hypertension","volume":"4","author":"Decker","year":"2011","journal-title":"Clin Transl Sci"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"e0167987","DOI":"10.1371\/journal.pone.0167987","article-title":"Relationship of iron deficiency and Serum ferritin levels with pulmonary hypertension: the Jackson heart study","volume":"11","author":"Jankowich","year":"2016","journal-title":"PLoS One"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijcard.2014.04.233","article-title":"Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: a pilot study","volume":"175","author":"Viethen","year":"2014","journal-title":"Int J Cardiol"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1086\/682217","article-title":"Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency","volume":"5","author":"Ruiter","year":"2015","journal-title":"Pulm Circ"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1513\/AnnalsATS.202009-1131OC","article-title":"Supplementation with iron in pulmonary arterial hypertension. Two randomized crossover trials","volume":"18","author":"Howard","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2023032507264026200_","doi-asserted-by":"crossref","first-page":"2000616","DOI":"10.1183\/13993003.00616-2020","article-title":"Oral iron supplementation with ferric maltol in patients with pulmonary hypertension","volume":"56","author":"Olsson","year":"2020","journal-title":"Eur Respir J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/1\/14\/49630320\/ehac569.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/1\/14\/49630320\/ehac569.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T21:31:33Z","timestamp":1701120693000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/44\/1\/14\/6772672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,10,25]]},"published-print":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehac569","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,10,25]]}}}